Background
The production of variation in adipose tissue accretion represents a key fetal adaptation to energy substrate availability during gestation. Because umbilical venous blood transports nutrient substrate from the maternal to the fetal compartment, and the fetal liver is the primary organ where nutrient inter-conversion occurs, it has been proposed that variations in the relative distribution of umbilical venous blood flow shunting either through ductus venosus or perfusing the fetal liver represents a mechanism underlying this adaptation.
Objective
The objective of the present study was to determine whether fetal liver blood flow assessed before the period of maximal fetal fat deposition (i.e., the third trimester of gestation) is prospectively associated with newborn adiposity.
Study design
A prospective study was conducted in a cohort of 62 uncomplicated singleton pregnancies. Fetal ultrasonography was performed at 30 weeks gestation for conventional fetal biometry and characterization of fetal liver blood flow (fLBF; quantified by subtracting ductus venosus flow from umbilical vein flow). Newborn body fat percentage was quantified by Dual Energy X-Ray Absorptiometry (DXA) imaging at 25.8 ± 3.3 (mean ± SEM) postnatal days. Multiple regression analysis was used to determine the proportion of variation in newborn body fat percentage explained by fLBF. Potential confounding factors included maternal age, parity, pre-pregnancy body mass index (ppBMI), gestational weight gain, gestational age at birth, infant sex, postnatal age at DXA scan, and mode of infant feeding.
Results
Newborn body fat percentage was 13.5 ± 2.4% (mean ± SEM). fLBF at 30 weeks gestation was significantly and positively associated with newborn total fat mass (r = 0.397, p < 0.001) and body fat percentage (r = 0.369, p = 0.004), but not with lean mass (r = 0.100, p = 0.441). After accounting for the effects of covariates, fLBF explained 13.5% of the variance in newborn fat mass. The magnitude of this association was particularly pronounced in non-overweight/non-obese mothers (ppBMI <25, n = 36), in whom fLBF explained 24.4% of the variation in newborn body fat percentage.
Conclusions
fLBF at the beginning of the third trimester of gestation is positively associated with newborn adiposity, particularly among non-overweight/non-obese mothers. This finding supports the role of fLBF as a putative fetal adaptation underlying variation in adipose tissue accretion.